Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    The news list adds October 2026 releases covering endometrial cancer trial results, a Merck–Moderna study presentation, and European Commission approval of a bladder cancer treatment. Several late-September releases are no longer listed.
    Difference
    5%
    Check dated 2026-10-28T01:08:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The listing now features Merck’s announcement of its new ADVANCE Bioanalytical Facility in West Point, Pennsylvania, in place of a September 22 release about a WINREVAIR label update. The total number of releases increased from 1,966 to 1,967.
    Difference
    5%
    Check dated 2026-10-21T01:11:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The listing now features October 2026 announcements, including Paul J. Diaz’s election to Merck’s board and new clinical results, while September 2026 releases about KEYTRUDA and HIV care are no longer among the displayed entries. The listing count also changes from 1,963 to 1,966 total releases.
    Difference
    5%
    Check dated 2026-10-14T02:15:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The news release list adds an announcement about Merck’s third-quarter 2026 earnings call and a report that tulisokibart met key endpoints in a Phase 2b study. The displayed total increases from 1,961 to 1,963 releases.
    Difference
    5%
    Check dated 2026-10-07T01:18:01.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    New items have been added to the News releases page, including a global license agreement with SciBrunch Therapeutics for SPR2015, withdrawal of the Ifinatamab Deruxtecan BLA for extensive-stage SCLC, FDA approval of WELIREG plus LENVIMA for ccRCC, and Remigromig showing positive results in diabetic macular edema. Older posts have been removed from the listing to maintain a current-news focus.
    Difference
    5%
    Check dated 2026-09-30T01:34:37.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Three new press releases dated September 22, 2026; September 21, 2026; and September 18, 2026 have been added to the News releases list, expanding the current roster of Merck's announcements. Older releases from July 2026 were removed from the listing.
    Difference
    5%
    Check dated 2026-09-23T01:11:26.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.